Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 51 - 75 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
4-Oxoretinol	Experimental	KRT18	3875	upregulated	4-oxoretinol results in increased expression of KRT18 mRNA	12q13.13	A20405
4-Oxoretinol	Experimental	KRT19	3880	upregulated	4-oxoretinol results in increased expression of KRT19 mRNA	17q21.2	A20405
4-Oxoretinol	Experimental	KRT7	3855	upregulated	4-oxoretinol results in increased expression of KRT7 mRNA	12q13.13	A20405
4-Oxoretinol	Experimental	KRT8	3856	upregulated	4-oxoretinol results in increased expression of KRT8 mRNA	12q13.13	A20405
4-Oxoretinol	Experimental	MCL1	4170	downregulated	4-oxoretinol results in decreased expression of MCL1 mRNA	1q21.2	A20405
4-Oxoretinol	Experimental	MEIS1	4211	upregulated	4-oxoretinol results in increased expression of MEIS1 mRNA	2p14	A20405
4-Oxoretinol	Experimental	MEIS2	4212	upregulated	4-oxoretinol results in increased expression of MEIS2 mRNA	15q14	A20405
4-Oxoretinol	Experimental	MEOX1	4222	upregulated	4-oxoretinol results in increased expression of MEOX1 mRNA	17q21.31	A20405
4-Oxoretinol	Experimental	MUC5AC	4586	upregulated	4-oxoretinol results in increased expression of MUC5AC mRNA	11p15.5	A20405
4-Oxoretinol	Experimental	OLR1	4973	upregulated	4-oxoretinol results in increased expression of OLR1 mRNA	12p13.2	A20405
4-Oxoretinol	Experimental	RARA	5914	upregulated	4-oxoretinol results in increased expression of RARA mRNA	17q21.2	A20405
4-Oxoretinol	Experimental	RARRES1	5918	upregulated	4-oxoretinol results in increased expression of RARRES1 mRNA	3q25.32	A20405
4-Oxoretinol	Experimental	RARRES3	5920	upregulated	4-oxoretinol results in increased expression of RARRES3 mRNA	11q12.3	A20405
4-Oxoretinol	Experimental	TGM2	7052	upregulated	4-oxoretinol results in increased expression of TGM2 mRNA	20q11.23	A20405
4-Phenylbutylamine	Experimental	ABCC4	10257	upregulated	4-phenylbutylamine results in increased expression of ABCC4 mRNA	13q32.1	A20406
Phenylbutyric acid	Approved Investigational	AARS	16	downregulated	4-phenylbutyric acid results in decreased expression of AARS mRNA	16q22.1	A20407
Phenylbutyric acid	Approved Investigational	AARS	16	upregulated	4-phenylbutyric acid results in increased expression of AARS mRNA	16q22.1	A20407
Phenylbutyric acid	Approved Investigational	AHSA1	10598	upregulated	4-phenylbutyric acid results in increased expression of AHSA1 mRNA	14q24.3	A20407
Phenylbutyric acid	Approved Investigational	AJUBA	84962	downregulated	4-phenylbutyric acid results in decreased expression of AJUBA mRNA	14q11.2	A20407
Phenylbutyric acid	Approved Investigational	AKR1C1	1645	upregulated	4-phenylbutyric acid results in increased expression of AKR1C1 mRNA	10p15.1	A20407
Phenylbutyric acid	Approved Investigational	BCL6	604	upregulated	4-phenylbutyric acid results in increased expression of BCL6 mRNA	3q27.3	A20407
Phenylbutyric acid	Approved Investigational	CARS	833	downregulated	4-phenylbutyric acid results in decreased expression of CARS mRNA	11p15.4	A20407
Phenylbutyric acid	Approved Investigational	CARS	833	upregulated	4-phenylbutyric acid results in increased expression of CARS mRNA	11p15.4	A20407
Phenylbutyric acid	Approved Investigational	CITED2	10370	downregulated	4-phenylbutyric acid results in decreased expression of CITED2 mRNA	6q24.1	A20407
Phenylbutyric acid	Approved Investigational	CLDN1	9076	downregulated	4-phenylbutyric acid results in decreased expression of CLDN1 mRNA	3q28	A20407

Displaying entries 51 - 75 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability